China health-supplement marketing claims: what you can say and what gets you delisted
Here's the short version on China health-supplement marketing claims: you can describe what the product is, what it contains, and how people use it. You cannot promise it cures, treats or prevents disease, compare it to drugs, or hang the pitch on a celebrity or expert endorsement. Brands that get delisted rarely did something exotic. They wrote a benefit line a home-market agency would call normal, a creator repeated it in a livestream, and a platform's review system caught it.
Supplements are the category where foreign brands most often mistake "popular" for "permitted." Chinese consumers want them, the wellness wave is real (I wrote about it in the yangsheng piece), and the temptation is to borrow the claim language that works in Sydney or Los Angeles. In China that language is the product's biggest liability. A caveat before anything else: I'm a marketer, not a lawyer, and these rules shift. Treat this as a map of where the cliffs are, and get current regulatory advice on your specific product before you publish.
Start with the regulatory status, because the claims depend on it
What you are allowed to say starts with what the product legally is in China. "Health food" is a regulated category with its own registration or filing route (the one that produces the blue-hat logo you see on packs sold in pharmacies and other offline retail). A product sold through cross-border e-commerce travels a different route: historically, health foods were left off the cross-border retail positive list because they were meant to be registered or filed, and the list has been revised over the years. The rules for overseas manufacturers selling this way have also been changing recently. I could not confirm every detail of the latest notices from primary sources, so check the customs and market-regulator announcements directly rather than trusting a vendor blog, including this one.
The marketing consequence is simple. Whichever route you use, advertising rules apply to what you say in China, wherever the stock sits. "It's a cross-border product, so the rules are looser" is the sentence I would most like to delete from entry decks.
What the advertising rules generally prohibit for health foods
China's Advertising Law has specific provisions for health food advertising, and the market regulator has added internet-advertising rules, in force since May 2023, that apply to online copy. In plain language, the recurring limits are these:
| Do not do this | Why it gets flagged | Safer framing |
|---|---|---|
| "Lowers blood pressure," "helps prevent diabetes," "supports cancer recovery" | Disease prevention or treatment claims are off limits for health foods | Describe ingredients and intended daily-use context, not a medical outcome |
| "Works better than medication" or comparisons with other products' efficacy | Comparing with drugs or other health foods is restricted | Say what your product is, not what it replaces |
| A celebrity, doctor or "expert" recommending it | Endorsements or recommendations by endorsers are restricted for this category, and regulators have made the celebrity point explicit | Plain brand-voice content and honest, unscripted user experience, reviewed for claims |
| An "educational" article or "health tip" that ends at your product | Content dressed up as news or popular science can be treated as disguised advertising | Label commercial content as commercial; keep education actually educational |
| No disclaimer on the ad | Health food ads are expected to carry the warning that the product does not substitute for drugs | Build the required wording into every creative template, including video |
Some of these have a recent paper trail: regulators have publicly named and shamed health-food advertisers for breaches, and have spelled out the no-celebrity-endorsement position. If you want to read the underlying reporting, trade outlets such as NutraIngredients and FoodNavigator have covered the rules as they changed.
Where brands actually get caught: the content you don't write
The brand's own product page is usually the cleanest asset in the whole funnel. The risk sits downstream:
- Livestream hosts. Scripts drift. A host with a good night improvises "my mother's blood sugar came down." Brief the host, give them a banned-phrase list, and review replays.
- KOC and KOL posts. A creator's honest personal story can still be an unlawful disease claim in an ad context. Contracts should require pre-approval of copy and give you takedown rights.
- Distributors and resellers. They will happily reuse your overseas claims. Your English-language website is part of the evidence trail.
- Reviews and comments. A customer writing "cured my insomnia" under your listing is an uncomfortable problem. Moderate and remove it.
- Translation of your global claims. A literal translation of "supports heart health" can land harder in Chinese than the English does at home. Re-clear, don't translate.
What delisting really costs
Platforms such as Tmall, JD and Douyin run their own content rules on top of the law, and their moderation is usually faster than any regulator. The sequence I see described most often is: a flagged listing or video, a platform warning, then restrictions on the shop or product page. I won't give you a fine schedule, because I can't verify current figures and they vary by case. The real cost is the pause: a flagship sitting offline in the weeks around a major promotion, plus the trust you spent building with affiliates and creators who now have to take posts down.
A workable compliance routine for a foreign supplement brand
- Settle the status first. Know whether you are selling as registered or filed health food, as a general food, or through a cross-border route, and what claims that status allows.
- Write a claims bible. One document: approved phrases in Chinese, banned phrases, required disclaimers, and who signs off. Every agency, host and creator gets it.
- Review in Chinese, by someone qualified. A local compliance advisor or lawyer reading the Chinese, not your regional manager reading the English.
- Audit the live surface monthly. Product pages, top-selling creator posts, livestream clips, reseller shops, comment sections.
- Make creators contractually accountable. Pre-approval, removal on request, and no improvised health claims.
Bottom line
In China health-supplement marketing, the strong claim is rarely the strong move. The brands that last sell on ingredient provenance, daily ritual, and honest experience, and they treat claim review as a standing part of the process, not a cleanup after a warning. A conservative line you can keep publishing beats an aggressive one that takes your flagship offline in the middle of 618 or Double 11.
If you're planning a supplement or wellness launch into Greater China and want a second read on positioning before the regulatory review, that's the work I do: reach out. If your launch leans on live commerce, the earlier piece on the cross-border sequence covers what to validate first.